New Nordic Healthbrands AB (publ) (STO:NNH)

Revenue by Segment

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Sales of Dietary Supplements, Herbal Medicines & Related Personal Care Products	576.36M	550.31M	533.85M	487.50M	514.85M
Total	576.36M	550.31M	533.85M	487.50M	514.85M

Revenue by Geography

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
The Nordic	157.00M	157.73M	168.64M	155.04M	170.57M
Europe	241.23M	202.47M	194.49M	186.98M	200.49M
North America	155.97M	163.37M	146.71M	127.93M	125.20M
Rest of the World	22.17M	26.74M	24.01M	17.55M	18.59M
Total	576.36M	550.31M	533.85M	487.50M	514.85M

Data Source: S&P Global Market Intelligence Last updated: Jul 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 22, 2026

Data Sources Report a data error